1.
Clin Case Rep
; 9(8): e04713, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34466263
RESUMO
Elexacaftor/tezacaftor/ivacaftor (ETI) is a cystic fibrosis (CF) transmembrane regulator (CFTR) modulator. It is known to be efficacious in stable patients with severe pneumopathy, but there are few data concerning its effectiveness during acute exacerbations. We here describe its use in a woman with CF and respiratory failure.